Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|September 19, 2007
Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhageIvelina Gueorguieva, Simon R Clark, Catherine J McMahon, et al.
European Journal of Immunology|November 5, 2014
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunityJames A Giles, Andrew D Greenhalgh, Claire L Davies, et al.
Nature Chemical Biology|October 25, 2011
Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computingBen G Small, Barry W McColl, Richard Allmendinger, et al.
Brain, Behavior, and Immunity|November 19, 2016
Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemiaJesus M Pradillo, Katie N Murray, Graham A Coutts, et al.
Journal of Neuroinflammation|January 4, 2014
The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialNavneet Singh, Stephen J Hopkins, Sharon Hulme, et al.
European Journal of Immunology|December 23, 2015
Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP systemWesam H Abdulaal, Catherine R Walker, Ryan Costello, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 12, 2012
Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid ratsJesus M Pradillo, Adam Denes, Andrew D Greenhalgh, et al.
Journal of Neuroinflammation|November 27, 2012
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infectionStephen J Hopkins, Catherine J McMahon, Navneet Singh, et al.
Journal of Neurotrauma|November 1, 2007
Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1raPeter J Hutchinson, Mark T O'Connell, Nancy J Rothwell, et al.
Stroke|March 24, 2018
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 TrialCraig J Smith, Sharon Hulme, Andy Vail, et al.
Pageof 9